Publications | Lund University Publications

1 – 7 of 7

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author+exact+%22onk-mfe%22&q=author+exact+%22pat-gla%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2011
Mark A non-functional retinoblastoma tumor suppressor (RB) pathway in premenopausal breast cancer is associated with resistance to tamoxifen.
Lehn, Sophie ^LU ; Fernö, Mårten ^LU ; Jirström, Karin ^LU ; Rydén, Lisa ^LU and Landberg, Göran ^LU (2011) In Cell Cycle 10(6). p.956-962
- Contribution to journal › Article
2009
Mark Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer.
Jögi, Annika ^LU ; Brennan, Donal J ; Rydén, Lisa ^LU ; Magnusson, Kristina ; Fernö, Mårten ^LU ; Stål, Olle ; Borgquist, Signe ^LU ; Uhlen, Mathias ; Landberg, Göran ^LU and Påhlman, Sven ^LU , et al. (2009) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 22. p.1564-1574
- Contribution to journal › Article
2008
Mark HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
Rydén, Lisa ^LU ; Landberg, Göran ^LU ; Stal, Olle ; Nordenskjold, Bo ; Fernö, Mårten ^LU and Bendahl, Pär-Ola ^LU (2008) In Breast Cancer Research and Treatment 109(2). p.351-357
- Contribution to journal › Article
Mark Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern.
Berglund, Pontus ^LU ; Stighall, Maria ^LU ; Jirström, Karin ^LU ; Rydén, Lisa ; Fernö, Mårten ^LU ; Nordenskjold, Bo and Landberg, Göran ^LU (2008) In Journal of Clinical Pathology 61. p.184-191
- Contribution to journal › Article
2005
Mark Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
Rydén, Lisa ^LU ; Jirström, Karin ^LU ; Bendahl, Pär-Ola ^LU ; Fernö, Mårten ^LU ; Nordenskjöld, Bo ; Stål, Olle ; Thorstenson, Sten ; Jönsson, Per-Ebbe ^LU and Landberg, Göran ^LU (2005) In Journal of Clinical Oncology 23(21). p.4695-4704
- Contribution to journal › Article
Mark Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial.
Jirström, Karin ^LU ; Rydén, Lisa ^LU ; Anagnostaki, L ; Nordenskjold, B ; Stal, O ; Thorstenson, S ; Chebil, G ; Jonsson, P-E ; Fernö, Mårten ^LU and Landberg, Göran ^LU (2005) In Journal of Clinical Pathology 58(11). p.1135-1142
- Contribution to journal › Article
2003
Mark Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence.
Jirström, Karin ^LU ; Ringberg, Anita ^LU ; Fernö, Mårten ^LU ; Anagnostaki, L and Landberg, Göran ^LU (2003) In British Journal of Cancer 89(10). p.1920-1926
- Contribution to journal › Article

your query:: Remove author: Fernö, Mårten (LU); Remove author: Landberg, Göran (LU)